References
- Wang RY. Chemotherapeutics: methotrexate. In: Hoffman RS, Howland M, Lewin NA, et al., editors. Goldfrank’s Toxicologic Emergencies, 10th ed. New York (NY): McGraw-Hill; 2015. p. 689–697.
- Methotrexate. Micromedex solutions [Internet]. Ann Arbor, MI: Truven Health Analytics, Inc; [cited 2016 Aug 24]. Available from: http://www.micromedexsolutions.com
- McKendry RJ, Dale P. Adverse effects of low dose methotrexate therapy in rheumatoid arthritis. J Rheumatol. 1993;20:1850–1856.
- Sinicina I, Mayr B, Mall G, et al. Deaths following methotrexate overdose by medical staff. J Rheumatol. 2005;32:2009–2011.
- Bebarta VS, Hensley MD, Borys DJ. Acute Methotrexate Ingestions in Adults: a Report of Serious Clinical Effects and Treatments. J Toxicol. 2014;2014: DOI: 10.1155/2014/214574.
- Gibbon BN, Manthey DE. Pediatric case of accidental oral overdose of methotrexate. Ann Emerg Med. 1999;34:98–100.
- Pruit AW, Kinkade JM, Patterson JH. Accidental ingestion of methotrexate. J Pediatr. 1974;85:686–688.
- Badurdeen S, Kang SL, Saravanan M. Accidental methotrexate ingestion in a 19-month old child. BMJ Case Reports. 2011. DOI: 10.1136/bcr.11.2010.3477
- Hensley MD, Berbarta VS, Borys DJ. A large case series of acute pediatric methotrexate ingestions: significant clinical effects are rare. Ped Emerg Care. 2016;32:682–684.
- Stoller RG, Hande KR, Jaccobs SA, et al. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity. N Engl J Med. 1977;297:630–634.
- Bleyer WA. New vistas for leucovorin in cancer chemotherapy. Cancer. 1989;63:995–1007.
- Chan BS, Sawson AH, Buckley NA. What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning? Clin Toxicol. 2017;55:88–96.
- Mowry JB, Spyker DA, Brooks DE, et al. 2014 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 32nd Annual Report. Clin Toxicol. 2015;53:962–1147.
- Hanley JA, Lippman-Hand A. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA. 1983;249:1743–1745.
- Smith SW, Nelson LS. Case files of the New York City Poison Control Center: antidotal strategies for the management of methotrexate toxicity. J Med Toxicol. 2008;4:132–140.
- Bradley AM, Buie LW, Kuykendal A, et al. Successful use of intrathecal carboxypeptidase G2 for intrathecal methotrexate overdose: a case study and review of the literature. Clin Lymphoma Myeloma Leuk. 2013;13:166–170.
- Kazanci E, Gulen H, Ayse E, et al. Treatment of intrathecal methotrexate overdose with folinic acid rescue and lumbar cerebrospinal fluid exchange: a report of two cases. Turk J Hematol. 2011;28:63–67.
- LoVecchio F, Kenneth DK, Watts DJ, et al. Four-year experience with methotrexate exposures. J Med Toxicol. 2004;4:149–150.
- Chabner BA, Young RC. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues. J Clin Invest. 1973;52:1804–1811.
- Roenigk HH, Auerbach R, Maibach H, et al. Methotrexate in psoriasis: consensus conference. J Am Acad Dermatol. 1998;38:478–485.